CN Stock MarketDetailed Quotes

600521 Zhejiang Huahai Pharmaceutical

Watchlist
  • 18.65
  • +0.10+0.54%
Not Open Nov 4 15:00 CST
27.35BMarket Cap24.00P/E (TTM)

Zhejiang Huahai Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Huahai Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
2.12B
--
+10.76%
Net Income
--
282.90M
--
+88.14%
Analyst Rating
Strong Buy

Nov 4, 2024

Zhejiang Huahai Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 31, 20242024/Q32.119B / ----
Aug 31, 20242024/Q22.630B / ----
Apr 30, 20242024/Q12.499B / ----
Oct 31, 20232023/Q31.913B / ----
Aug 31, 20232023/Q22.235B / ----
DatePeriodRevenue/EstimateEarnings Call
Oct 31, 20242024/Q32.119B / ----
Aug 31, 20242024/Q22.630B / ----
Apr 30, 20242024/Q12.499B / ----
Oct 31, 20232023/Q31.913B / ----
Aug 31, 20232023/Q22.235B / ----

Unlock Free Earnings Estimates

Zhejiang Huahai Pharmaceutical Earnings Reports

  • Huahai Pharmaceutical: Zhejiang Huahai Pharmaceutical Co., Ltd. Third Quarter Report 2024

    Oct 30 12:00 ET

  • Zhejiang Huahai Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Oct 30 12:00 ET

  • Zhejiang Huahai Pharmaceutical Co., Ltd. Pre-performance announcement for the first three quarters of 2024

    Oct 9 12:00 ET

  • Summary of the 2024 semi-annual report of Zhejiang Huahai Pharmaceutical Co., Ltd.

    Aug 30 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 4, 2024

    Strong Buy

    • Strong Buy

      85.71%

    • Buy

      14.29%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data